( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Semler Scientific, Inc. ("Semler" or the"Company") (NASDAQ:SMLR) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at ..., or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until October 28, 2025 to ask the Court to appoint them as lead plaintiff. [CONTACT THE FIRM IF YOU SUFFERED A LOSS ] What Happened? On February 28, 2025, Semler filed its Form 10-K with the SEC and therein, disclosed that the Company received an initial civil investigative demand from the U.S. Department of Justice in July 2017 regarding Semler's claims for reimbursement related to the QuantaFlo device. Semler received subsequent requests for information in February 2019, December 2021, April 2022, and April 2023. In February 2025, Semler participated in settlement discussions with the DOJ, which were unsuccessful.